Your session is about to expire
← Back to Search
Metronidazole for Crohn's Disease
Phase 4
Waitlist Available
Led By Sandra Kavalukas, MD
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
20-80 years old who is deemed an acceptable surgical candidate for ileocolic resection.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six months
Awards & highlights
Study Summary
This trial will compare two types of post-operative treatment for Crohn's disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ six months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in bacteria in the gut
Trial Design
2Treatment groups
Active Control
Group I: Standard careActive Control1 Intervention
Standard post-operative care, which may or may not include post-operative antibiotics
Group II: MetronidazoleActive Control1 Intervention
Metronidazole 250 mg three times a day
Find a Location
Who is running the clinical trial?
University of LouisvilleLead Sponsor
338 Previous Clinical Trials
75,976 Total Patients Enrolled
Sandra Kavalukas, MDPrincipal InvestigatorUniversity of Louisville
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger